Subject: RXMD Announces Additional Expansion Efforts in New Material Definitive Agreement

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RXMD Announces Additional Expansion Efforts in New Material Definitive Agreement
Hot Stock to WatchHot Stock to Watch

Company: Progressive Care Inc. (OTCQB: RXMD)


Price: 0.052

Change (%): + 0.002 (4.00)

Volume: 31,548
RXMD Chart

Entry into a Material Definitive Agreement

MIAMI, Dec. 21, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB: RXMD) (the “Company”) a personalized healthcare services and technology company, announced today that, through its wholly-owned subsidiary, PharmCo, LLC, the Company closed on the purchase agreement with 400 Ansin, LLC (the “Seller”) for the purchase of two condominium units in Hallandale Beach, Florida. The Company paid the aggregate amount of $1,860,000 for the condominium units.

The Company issued a convertible promissory note (the “Note”) in the amount of $300,000 to the Seller to fund a portion of the price for such purchase. The Note bears interest at the rate of 10% per annum and is payable in full 27 months from the date of issuance. The outstanding principal and interest then payable under the Note is convertible into shares of the Company’s common stock 12 months after the date of issuance at the price per share equal to the average trading-price for the common stock during the three (3) trading day period ending on the latest complete trading day prior to the conversion date. The Company also executed a mortgage in the amount of $1,530,000 bearing interest at a rate of 4.75% per annum which is payable over the course of 119 months. The Company will pay a 3% real-estate commission, which can be paid in cash or stock at the Company’s discretion.

The Company plans to relocate pharmacy operations, administrative offices, telepharmacy and long-term care services from its current leased space in North Miami Beach to the purchased facility. The company will begin the process of securing constructions permits for the buildout of the space, and upon completion will apply for all necessary pharmacy licenses and contracts.

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks